IBO
AMEX Impact BioMedical, Inc.$4.11 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.11, $0.30 below the day’s high of $4.41
- YTD change
- -35.51%
- vs 20-day SMA
- -30.52%
- vs 200-day SMA
- -36.80%
Price ranges
Price & Performance
+3.40 (+478.87%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 94.7% away from all-time highs of $77.87
- IBO is down 36% since the beginning of the year
- IBO is down 47% over the past 12 months
- IBO is down 34% over the past 1 month
- 1% of all IBO investors are betting against IBO
- Number of investors short IBO has gone up 5% versus last month
IBO reads poor: price sits below both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +565.7%.
- Previous minute
- -$0.04
- Last hour
- +$0.00
- Last 5 days
- -26.61%
- vs 8-day SMA
- -20.89%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
